NCT06438653

Brief Summary

We aimed to investigate the incidence of reinterventions in patients who underwent thoracic endovascular aortic repair (TEVAR) in multiple centers across Taiwan

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 20, 2025

Status Verified

February 1, 2025

Enrollment Period

1.4 years

First QC Date

May 27, 2024

Last Update Submit

July 16, 2025

Conditions

Thoracic Endovascular Aortic Repair

Keywords

Thoracic endovascular aortic repairReinterventions

Outcome Measures

Primary Outcomes (1)

  • Reintervention

    The incidence of reinterventions in patients who underwent thoracic endovascular aortic repair (TEVAR)

    7 years

Secondary Outcomes (1)

  • Mortality

    7 years

Study Arms (1)

Thoracic endovascular aortic repair

Other: No-intervenyion

Interventions

No-intervenyionOTHER

No-intervenyion

Thoracic endovascular aortic repair

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who underwent thoracic endovascular aortic repair (TEVAR) in multiple centers across Taiwan.

You may qualify if:

  • Patients who underwent thoracic endovascular aortic repair (TEVAR)

You may not qualify if:

  • No thoracic endovascular aortic repair (TEVAR)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

Location

Study Officials

  • Chih-Yang Chan, phd

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2024

First Posted

June 3, 2024

Study Start

January 18, 2024

Primary Completion

June 20, 2025

Study Completion

October 1, 2025

Last Updated

July 20, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Locations

TW(1)